CDNA Q3 2022 Earnings — CareDx, Inc Revenue & Financial Results | Market Cap Arena

CDNACareDx, Inc

$889M

Q3 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$79M+5.0% YoY

Gross Profit

$51M64.3% margin

Operating Income

-$17M-21.8% margin

Net Income

-$17M-21.3% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

-1.6%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$13M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$545M

Total Liabilities

$108M

Stockholders' Equity

$437M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$79M	$76M	+5.0%
Gross Profit	$51M	$51M	+0.6%
Operating Income	-$17M	-$9M	-98.7%
Net Income	-$17M	-$12M	-42.4%

Geographic Segments

UNITED STATES

$65M96%

Europe

$2M3%

Rest Of The World

$204,0000%